Research offers clearer genetic blueprint of breast cancer variants
A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore),…
International trial proves AI can design gold-standard cancer treatment plans
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer,…
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs.…
Fewer radiotherapy sessions for prostate cancer show minimal side effects
Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five…
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Melanoma cells appear to rely on a hidden genetic partnership to keep dividing far beyond their normal lifespan.…
Cancer-causing protein also helps tumors repair their DNA
Rosalie Sears, Ph.D., is senior author of a new study published in Genes & Development. Her team at…
Does the PSA test for prostate cancer save lives? New data reverse gold-standard findings
Prostate cancer (cells, artificially coloured) affected 1.5 million people worldwide in 2022.Credit: Dr Gopal Murti/Science Photo Library Does…
Multi-institutional trial explores new lifeline for advanced prostate patients
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited…
Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity
Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset…
Scientists identify methylphenidate as an effective tool for combating chronic cancer related fatigue
A new meta-analysis in the May 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network provides updated…
Four OICR-funded studies explore transformative approaches in cancer care
Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by…
Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive…